Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03360695
What this trial is testing

Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer

Who this might be right for
CancerSevere Major DepressionSchizophrenia+5 more
Massachusetts General Hospital 185
Testing effectiveness (Phase 2)Study completedNCT00615511
What this trial is testing

Efficacy of Pregnenolone in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Weill Medical College of Cornell University 100
Post-approval studies (Phase 4)Looking for participantsNCT05823532
What this trial is testing

Anti-Inflammatory Challenge in Schizophrenia

Who this might be right for
Schizophrenia
Emory University 60
Not applicableUnknownNCT05206292
What this trial is testing

Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.

Who this might be right for
Inherited Metabolic Disorder of Nervous SystemSchizophrenia
University Hospital, Grenoble 600
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Large-scale testing (Phase 3)Study completedNCT01888107
What this trial is testing

Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen-Cilag S.p.A. 347
Not applicableUnknownNCT02916121
What this trial is testing

Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Taipei Medical University WanFang Hospital 88
Not applicableEnded earlyNCT01177709
What this trial is testing

Metformin for Weight Loss in Schizophrenia

Who this might be right for
SchizophreniaObesity
Nathan Kline Institute for Psychiatric Research 12
Not applicableUnknownNCT06423651
What this trial is testing

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

Who this might be right for
SchizophreniaSchizophreniform DisordersDelusional Disorder+3 more
Universitat Autonoma de Barcelona 160
Early research (Phase 1)Study completedNCT00796081
What this trial is testing

A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 25
Post-approval studies (Phase 4)Study completedNCT00034801
What this trial is testing

Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

Who this might be right for
DepressionSchizophreniaSchizoaffective Disorder
Eli Lilly and Company 378
Early research (Phase 1)Study completedNCT00821600
What this trial is testing

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

Who this might be right for
Psychotic DisordersSchizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 24
Post-approval studies (Phase 4)Study completedNCT00847600
What this trial is testing

Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorders
Sha'ar Menashe Mental Health Center 60
Not applicableStudy completedNCT00686140
What this trial is testing

And Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

Who this might be right for
Schizophrenia
Beijing HuiLongGuan Hospital 200
Early research (Phase 1)Study completedNCT00791349
What this trial is testing

QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141
Not applicableUnknownNCT00330226
What this trial is testing

Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders

Who this might be right for
SchizophreniaBipolar Disorder
Seoul National University Hospital 500
Post-approval studies (Phase 4)Study completedNCT00191555
What this trial is testing

Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

Who this might be right for
Schizophrenia
Eli Lilly and Company 360
Early research (Phase 1)Study completedNCT04849026
What this trial is testing

Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18

Who this might be right for
Schizophrenia
Whanin Pharmaceutical Company 33
Large-scale testing (Phase 3)Study completedNCT00085748
What this trial is testing

Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 114
Large-scale testing (Phase 3)Study completedNCT00088465
What this trial is testing

Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenic DisordersSchizoaffective Disorder
Eli Lilly and Company 931
Next Page